Healio

Q&A: Expanded rollout of adenosine deaminase deficiency newborn screenings recommended

Please provide your email address to receive an email when new articles are posted on . T-receptor excision circle screenings can miss cases of adenosine deaminase deficiency (ADA), which can be fatal ...
Business Wire

FDA Approves Revcovi™, a New Enzyme Replacement Therapy Developed by Leadiant Biosciences, for the Treatment of ADA-SCID in Pediatric and Adult Patients

GAITHERSBURG, Md.--(BUSINESS WIRE)--Leadiant Biosciences, Inc. today announced that the Food and Drug Administration (FDA) has granted approval to Revcovi™ (elapegademase-lvlr) injection in the U.S.
Healio

Newborn screening strategy identifies otherwise missed adenosine deaminase deficiencies

Please provide your email address to receive an email when new articles are posted on . Including tandem mass spectroscopy in newborn screenings to identify adenosine deaminase deficiencies could save ...
EurekAlert!

Adenosine deaminase 2 regulates the activation of the toll-like receptor 9 in response to nucleic acids

Adenosine deaminase 2 (ADA2) has been identified as a regulator of toll-like receptor 9 (TLR9) activation in response to nucleic acids, according to a recent study. ADA2, previously known for its role ...
Monthly Prescribing Reference

Revcovi Approved for Adenosine Deaminase Severe Combined Immune Deficiency

The FDA approval was supported by data from 2 multicenter, open-label clinical trials (Study 1 [N=6] and Study 2 [N=4]) Leadiant Biosciences announced that the Food and Drug Administration (FDA) has ...
News Medical

ADA2 regulates inflammation through lysosomal and extracellular mechanisms

Adenosine deaminase 2 (ADA2) plays a critical role in immune regulation, particularly in monocyte differentiation and activation. Unlike ADA1, which primarily functions intracellularly, ADA2 can be ...